Background COVID-19, the disease caused by SARS-CoV-2 (severe acute respiratory
syndrome coronavirus 2) can present with symptoms ranging from none to severe …

COVID-19 is an ongoing public health emergency that has affected millions of people
worldwide and is still a threat to many more. One of the pathophysiological features of …

Background COVID-19 infection is characterised, among other features, by a prothrombotic
state with high rate of venous thromboembolism (VTE), D-dimer, and fibrinogen levels …

Background COVID-19 is accompanied by a hypercoagulable state and characterized by
microvascular and macrovascular thrombotic complications. In plasma samples from …

The 2019 coronavirus disease (COVID-19) is the disease caused by SARS-CoV-2 infection.
Although this infection has been shown to affect the respiratory system, a high incidence of …

The SARS-CoV-2 virus has spread to all corners of the world. Thrombosis is the cause of
organ failure and subsequent death in COVID-19. The pathophysiology of thrombosis in …

There is growing evidence supporting the idea that vascular occlusions in pulmonary and
systemic circulation are among the most severe and common causes of poor outcome in …

Abstract The coronavirus disease 2019 (COVID-19) increases thrombotic risk. The
mechanisms that lead to this prothrombotic state are not well established. The main aim was …

Patients with Coronavirus-associated disease-2019 (COVID-19) display alterations of the
hemostatic system and the presence of a prothrombotic status frequently leading to vascular …

COVID-19, caused by the SARS-CoV-2 virus, is responsible for a pandemic of unparalleled
portion over the past century. While the acute phase of infection causes significant morbidity …